Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
therapy. His work is world-leading, both in terms of a willingness to think outside the box and in terms of impact. More about John Haanen Prof. Haanen is an internist/oncologist, and immunotherapy research
-
with guidance in career development, scientific leadership, and personal growth.' Abena Amoah Disciplines Medical, biomedical or health sciences. Who is it for? Scientific researchers who work in the
-
institute to conduct research on the labour market and social security in the Netherlands. Potential subjects include trends and developments in sickness absenteeism and incapacity for work, labour market
-
-candidates and researchers with a PhD degree who work at (or are affiliated with) a university or research institute in the Kingdom of the Netherlands. Sustainable travel The KNAW values sustainability and
-
vaccines. Academy Beijerinck Premium recognition welcome Fros is delighted with the recognition of his work by the Academy Beijerinck Premium. His current research is project-related, but Fros hopes to be
-
Cornelia Beth-Pastoor. The Foundation’s aim is to continue and extend the work of the Dutch logician Evert Willem Beth. It encourages philosophical research and the teaching of philosophy by organising
-
, large-scale trade in zoo animals, and the reintroduction of endangered species). De Bont is a highly productive researcher whose work has been published by leading international science publishers and in
-
KNAW Van der Gaag Grant Behavioural Sciences, Social Sciences and Law Early career scientists The KNAW Van der Gaag Grant helps young behavioural researchers cover the cost of a research project or
-
prize for early-career researchers. A maximum of twelve awards are presented annually, with a maximum of three awards in each of the four Academy domains. Laureates each receive of a work of art and a sum
-
that researchers have been using ever since to study hepatitis C and test antiviral drugs. His work has led to pioneering new treatments for chronic liver infections. Bartenschlager has widened his scope to include